HSA is assessing the potential risk of suicidal thoughts and self-harm with glucagon-like peptide-1 receptor agonists (GLP-1 RA)
Surge in Dengue Cases Alarms Singapore in 2023
HSA Alert: Three Products Found to Contain Potent Medicinal Ingredients including High Levels of Banned Substance Sibutramine and Erectile Dysfunction Medicines
HSA Product Recall: Fluoxone Divule (fluoxetine) 20mg Tablet
HSA Product Recall: Mydriaticum (Tropicamide) Stulln® Eye Drops

A recent safety evaluation regarding the potential risk of suicidal thoughts and self-harm associated with glucagon-like peptide-1 receptor agonists (GLP-1 RA) has been initiated by some overseas regulatory authorities. This

|
October 3, 2023

Singapore has witnessed an alarming increase in weekly dengue cases, surpassing the 300-mark for the first time this year. According to data from the National Environment Agency (NEA), between September

|
October 2, 2023

The Health Sciences Authority (HSA) has issued a warning to the public against purchasing or consuming three products: 'Fercy Dietary Supplement Product,' 'TANDUK RUSA KUAT LELAKI,' and 'mentalk candy.' HSA's

|
October 2, 2023

Retail-level recall of four batches of Fluoxone Divule 20mg Tablet, containing fluoxetine, due to presence of an impurity. Date of recall:27 September 2023Product:Fluoxone Divule 20mg TabletActive Ingredient:FluoxetineProduct Category:Therapeutic productBatch No.:20J12B,

|
September 28, 2023

Retail-level recall of one batch of Mydriaticum (Tropicamide) Stulln® Eye Drops due to deviation in manufacturing process. Date of recall:18 Sep 2023Product:Mydriaticum (Tropicamide) Stulln® Eye Drops 0.5%, 10mlActive Ingredient:TropicamideProduct Category:Therapeutic

|
September 28, 2023
Filter

EXPLORE

About Us

Connect with US

Copyright © 2023 DocMed Technology Pte Ltd. All rights reserved.